• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用框架快速进行真实世界数据安全性信号评估分析。

Adopting a Framework for Rapid Real-World Data Analyses in Safety Signal Assessment.

机构信息

Janssen Research and Development LLC, The Pharmaceutical Companies of Johnson & Johnson, 200 Tournament Drive, Horsham, PA, 19044, USA.

BMS, New York, USA.

出版信息

Ther Innov Regul Sci. 2024 Nov;58(6):1014-1022. doi: 10.1007/s43441-024-00694-7. Epub 2024 Sep 6.

DOI:10.1007/s43441-024-00694-7
PMID:39242460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11530479/
Abstract

The expanding availability of real-world data (RWD) has led to an increase in both the interest and possibilities for using this information in postmarketing safety analyses and signal management. While there is enormous potential value from the safety insights generated through RWD, the analysis preparation, execution, and communication required to reliably deliver the evidence can be time consuming. Since the safety signal assessment process is a regulated and timebound process, any supporting RWD analyses require a rapid turnaround of well-designed and informative results. To address this challenge, a TransCelerate BioPharma working group was formed and developed a framework to help teams responsible for safety signal assessment overcome the challenges of working with RWD rapidly to deliver analyses within regulatory timelines. Here, a previously performed safety assessment was evaluated within the context of the developed framework to illustrate how the framework may be adopted in practice.

摘要

真实世界数据(RWD)的可用性不断扩大,使得利用这些信息进行上市后安全性分析和信号管理的兴趣和可能性都有所增加。虽然从 RWD 中产生的安全性见解具有巨大的潜在价值,但为了可靠地提供证据,所需的分析准备、执行和沟通可能会很耗时。由于安全性信号评估过程是一个受监管且限时的过程,因此任何支持性的 RWD 分析都需要快速提供精心设计且有信息价值的结果。为了应对这一挑战,一个 TransCelerate 生物制药工作组成立了,并制定了一个框架,帮助负责安全性信号评估的团队克服在监管时间内快速使用 RWD 开展分析的挑战。在此,根据所制定的框架对之前进行的安全性评估进行了评估,以说明如何在实践中采用该框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/44fb3013809e/43441_2024_694_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/312ec7bf626f/43441_2024_694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/16724a97cf47/43441_2024_694_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/7f92d9591bc1/43441_2024_694_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/44fb3013809e/43441_2024_694_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/312ec7bf626f/43441_2024_694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/16724a97cf47/43441_2024_694_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/7f92d9591bc1/43441_2024_694_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed0c/11530479/44fb3013809e/43441_2024_694_Fig4_HTML.jpg

相似文献

1
Adopting a Framework for Rapid Real-World Data Analyses in Safety Signal Assessment.采用框架快速进行真实世界数据安全性信号评估分析。
Ther Innov Regul Sci. 2024 Nov;58(6):1014-1022. doi: 10.1007/s43441-024-00694-7. Epub 2024 Sep 6.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Leveraging Real-World Data in Safety Signal Assessment.利用真实世界数据进行安全性信号评估。
Ther Innov Regul Sci. 2024 Nov;58(6):1062-1070. doi: 10.1007/s43441-024-00682-x. Epub 2024 Aug 6.
4
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
7
Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.监测网络论坛中的药物不良事件:一个管道的评估和应用案例研究。
J Med Internet Res. 2024 Jun 18;26:e46176. doi: 10.2196/46176.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
10
Understanding the Work of the Pharmacovigilance Risk Assessment Committee (PRAC): A Quantitative Review of the Post-Authorisation Safety Evaluation of Antidiabetic Drugs from 2012 to 2022.了解药物警戒风险评估委员会(PRAC)的工作:对2012年至2022年抗糖尿病药物上市后安全性评估的定量综述。
Drug Saf. 2025 Jul;48(7):781-794. doi: 10.1007/s40264-025-01536-7. Epub 2025 Mar 1.

本文引用的文献

1
Leveraging Real-World Data in Safety Signal Assessment.利用真实世界数据进行安全性信号评估。
Ther Innov Regul Sci. 2024 Nov;58(6):1062-1070. doi: 10.1007/s43441-024-00682-x. Epub 2024 Aug 6.
2
Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study.曲马多或可待因治疗后患髋部骨折的风险:一项观察性研究。
Drug Saf. 2022 Jul;45(7):791-807. doi: 10.1007/s40264-022-01198-9. Epub 2022 Jul 9.
3
Desiderata for the development of next-generation electronic health record phenotype libraries.下一代电子健康记录表型库发展的要点。
Gigascience. 2021 Sep 11;10(9). doi: 10.1093/gigascience/giab059.
4
Association of Tramadol Use With Risk of Hip Fracture.曲马多使用与髋部骨折风险的关联
J Bone Miner Res. 2020 Apr;35(4):631-640. doi: 10.1002/jbmr.3935. Epub 2020 Feb 5.
5
PheValuator: Development and evaluation of a phenotype algorithm evaluator.PheValuator:表型算法评估器的开发与评估。
J Biomed Inform. 2019 Sep;97:103258. doi: 10.1016/j.jbi.2019.103258. Epub 2019 Jul 29.